BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

NCT07492641 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1056

Enrollment

INDUSTRY

Sponsor class

Conditions

HR+/HER2- Breast Cancer

Interventions

DRUG: BGB-43395
DRUG: Letrozole
DRUG: Abemaciclib
DRUG: Palbociclib
DRUG: Ribociclib

Sponsor

BeOne Medicines